Medicis Rising: Dysport (aka Reloxin) Approved by FDA

The FDA has finally approved a Botox alternative for the US market. Formerly announced as Reloxin, Medicis' Dysport is the first of a small wave of so-called "Botox killers" we have been waiting for for some time. Dysport is

Botox Must Carry Strong Warning on Risks: U.S. FDA

Allergan Inc’s wrinkle-filler Botox and a similar product must carry a strong warning about the risks of severe complications if the injected botulinum toxin spreads in the body, U.S. regulators said today.

Study Says Weight Loss Surgery on the Rise

WellPoint research subsidiary HealthCore also found that patients of Blue Distinction Centers for Bariatric Surgery experienced fewer complications and infections during the 30-day period after surgery, compared to those who had the procedure done at

ASPS Fall Meeting Sked Reworked

Eliminating the extra half day of exhibit time would allow exhibit personnel to return to their offices earlier in the week.